Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 9 studies | 80% ± 26% | |
epithelial cell | 7 studies | 72% ± 21% | |
hepatocyte | 6 studies | 60% ± 32% | |
epithelial cell of proximal tubule | 6 studies | 54% ± 24% | |
goblet cell | 5 studies | 59% ± 12% | |
progenitor cell | 5 studies | 86% ± 11% | |
transit amplifying cell | 5 studies | 61% ± 23% | |
intestinal crypt stem cell | 4 studies | 60% ± 13% | |
T cell | 3 studies | 25% ± 6% | |
B cell | 3 studies | 33% ± 7% | |
mature NK T cell | 3 studies | 42% ± 16% | |
enteroendocrine cell | 3 studies | 41% ± 19% | |
brush cell | 3 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 62537.12 | 226 / 226 | 85% | 1154.77 | 345 / 406 |
intestine | 97% | 27501.22 | 939 / 966 | 66% | 437.41 | 347 / 527 |
stomach | 56% | 24.39 | 200 / 359 | 52% | 308.97 | 150 / 286 |
kidney | 100% | 9174.08 | 89 / 89 | 1% | 1.39 | 11 / 901 |
bladder | 67% | 11.05 | 14 / 21 | 20% | 104.75 | 101 / 504 |
muscle | 69% | 20.35 | 558 / 803 | 0% | 0 | 0 / 0 |
brain | 66% | 23.09 | 1754 / 2642 | 0% | 0 | 0 / 705 |
esophagus | 49% | 28.39 | 706 / 1445 | 9% | 15.42 | 16 / 183 |
spleen | 50% | 66.32 | 121 / 241 | 0% | 0 | 0 / 0 |
uterus | 49% | 19.12 | 83 / 170 | 1% | 12.27 | 5 / 459 |
prostate | 49% | 19.40 | 121 / 245 | 0% | 0 | 0 / 502 |
pancreas | 43% | 8.97 | 140 / 328 | 5% | 16.37 | 9 / 178 |
adrenal gland | 47% | 11.48 | 121 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 44% | 273.66 | 413 / 929 | 0% | 0 | 0 / 0 |
lung | 39% | 15.47 | 228 / 578 | 4% | 9.58 | 49 / 1155 |
thymus | 43% | 10.80 | 282 / 653 | 0% | 0 | 0 / 605 |
ovary | 42% | 12.43 | 76 / 180 | 0% | 0.22 | 1 / 430 |
breast | 37% | 182.07 | 172 / 459 | 0% | 0.32 | 1 / 1118 |
adipose | 29% | 14.95 | 348 / 1204 | 0% | 0 | 0 / 0 |
heart | 28% | 7.36 | 242 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 26% | 6.99 | 342 / 1335 | 0% | 0 | 0 / 0 |
skin | 22% | 6.44 | 400 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0032000 | Biological process | positive regulation of fatty acid beta-oxidation |
GO_0015909 | Biological process | long-chain fatty acid transport |
GO_0033552 | Biological process | response to vitamin B3 |
GO_0015908 | Biological process | fatty acid transport |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050892 | Biological process | intestinal absorption |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0045179 | Cellular component | apical cortex |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005634 | Cellular component | nucleus |
GO_0005324 | Molecular function | long-chain fatty acid transmembrane transporter activity |
GO_1901363 | Molecular function | heterocyclic compound binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0032052 | Molecular function | bile acid binding |
GO_0016209 | Molecular function | antioxidant activity |
GO_0005504 | Molecular function | fatty acid binding |
GO_0070538 | Molecular function | oleic acid binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FABP1 |
Protein name | Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) Fatty acid-binding protein, liver (L-FABP) (Liver-type fatty acid-binding protein) |
Synonyms | hCG_32947 FABPL |
Description | FUNCTION: Plays a role in lipoprotein-mediated cholesterol uptake in hepatocytes . Binds cholesterol . Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport (By similarity). . FUNCTION: Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport. . FUNCTION: Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport. . FUNCTION: Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport. . |
Accessions | Q6FGL7 Q05CP7 ENST00000295834.8 P07148 A8MW49 ENST00000393750.3 |